Ajimura, M., Leem, S. H. & Ogawa, H. Identification of new genes required for meiotic recombination in Saccharomyces cerevisiae. Genetics 133, 51-66

Department of Biology, Faculty of Science, Osaka University, Japan.
Genetics (Impact Factor: 5.96). 02/1993; 133(1):51-66.
Source: PubMed


Mutants defective in meiotic recombination were isolated from a disomic haploid strain of Saccharomyces cerevisiae by examining recombination within the leu2 and his4 heteroalleles located on chromosome III. The mutants were classified into two new complementation groups (MRE2 and MRE11) and eight previously identified groups, which include SPO11, HOP1, REC114, MRE4/MEK1 and genes in the RAD52 epistasis group. All of the mutants, in which the mutations in the new complementation groups are homozygous and diploid, can undergo premeiotic DNA synthesis and produce spores. The spores are, however, not viable. The mre2 and mre11 mutants produce viable spores in a spo13 background, in which meiosis I is bypassed, suggesting that these mutants are blocked at an early step in meiotic recombination. The mre2 mutant does not exhibit any unusual phenotype during mitosis and it is, thus, considered to have a mutation in a meiosis-specific gene. By contrast, the mre11 mutant is sensitive to damage to DNA by methyl methanesulfonate and exhibits a hyperrecombination phenotype in mitosis. Among six alleles of HOP1 that were isolated, an unusual pattern of intragenic complementation was observed.

4 Reads
  • Source
    • "Originally, Mre11 was identified in yeast, S. cerevisiae as a gene required for early steps of meiotic recombination, namely for induction as well as for repair of meiotic DSBs. Mutational analysis of the yeast MRE11 gene showed that its function in DSB initiation is located in the C-terminal part of the protein and is distinct from its end processing function which is associated with the N-terminal part of the protein [20,25,26]. Elucidating Mre11 function in vertebrates is hampered by the fact that null mutations in any component of the MRX complex cause embryonic lethality [27-29]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The evolutionary conserved Mre11/Rad50/Nbs1 complex functions as one of the guardians of genome integrity in eukaryotes; it is required for the double-strand break repair, meiosis, DNA checkpoint, and telomere maintenance. To better understand the role of the MRE11 gene in Arabidopsis, we performed comparative analysis of several mre11 alleles with respect to genome stability and meiosis. The mre11-4 and mre11-2 alleles presumably produce truncated MRE11 proteins composed of the first 499 and 529 amino acids, respectively. Although the putative MRE11 truncated proteins differ only by 30 amino acids, the mutants exhibited strikingly different phenotypes in regards to growth morphology, genome stability and meiosis. While the mre11-2 mutants are fully fertile and undergo normal meiosis, the mre11-4 plants are sterile due to aberrant repair of meiotic DNA breaks. Structural homology analysis suggests that the T-DNA insertion in the mre11-4 allele probably disrupted the putative RAD50 interaction and/or homodimerization domain, which is assumed to be preserved in mre11-2 allele. Intriguingly, introgression of the atm-2 mutant plant into the mre11-2 background renders the double mutant infertile, a phenotype not observed in either parent line. This data indicate that MRE11 partially compensates for ATM deficiency in meiosis of Arabidopsis.
    PLoS ONE 10/2013; 8(10):e78760. DOI:10.1371/journal.pone.0078760 · 3.23 Impact Factor
  • Source
    • "However, there are mutants of the MRN(X) complex that are competent for Spo11 cleavage, but which are unable to remove the covalently bound Spo11 protein. These include alleles of Rad50 (termed rad50-S, (Cao et al. 1990)) and nuclease-deficient alleles of Mre11 (Ajimura et al. 1993; Moreau et al. 1999). Interestingly, the same phenotype is seen in null alleles of Sae2 (Keeney and Kleckner 1995; Prinz et al. 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: 18.1 Introduction Topoisomerase II (Top2) is an important anticancer drug target. Agents such as etoposide and doxorubicin are broadly used in a wide variety of malignancies (Baldwin and Osheroff 2005; Choi et al. 2008; Dombernowsky et al. 1996; Lieu et al. 2009; Verborg et al. 2008; Walker and Nitiss 2002). Most drugs that target Top2 generate DNA damage as a direct consequence of the catalytic activity of the enzyme. All topoisomerases cleave DNA by forming a covalent complex between the enzyme and DNA, and agents that perturb the catalytic cycle have the potential to trap the enzyme and introduce DNA damage. The DNA damage caused by interfering with a topoisomerase is unique because it includes both DNA strand breaks and protein covalently bound to DNA. Agents that lead to the trapping of topoisomerases on DNA have been termed topoisomerase poisons to highlight the importance of cellular damage induced by these agents. Because topoisomerase poisons lead to cell killing largely through enzyme-mediated damage, pathways that repair this damage are critical determinants of clinical response to these agents. A major goal of this chapter is to highlight our current understanding of how DNA repair pathways affect sensitivity to Top2 poisons. It is hoped that some of these concepts will lead to new approaches for the clinical application of Top2 targeting agents. In addition to the clinical importance of Top2 targeting agents, these drugs have served as model compounds to study cellular responses to DNA damage. Unlike ionizing radiation or alkylating agents, many Top2 targeting drugs are highly specific,
    DNA Topoisomerases and Cancer, 1st edited by Y. Pommier, 01/2012: chapter 18: pages 381-407; Springer., ISBN: 978-1-4614-0323-4
  • Source
    • "Our functional analyses of a comprehensive histone point mutant library showed 90 MMS-sensitive mutants (Matsubara et al. 2007; Sakamoto et al. 2009). As most HR mutants show MMS sensitivity (Ajimura et al. 1993), these MMS-sensitive histone point mutants are potentially defective in one or more types of HR. Among these, H2A-S128A (see Introduction ) and H3-K56A (in this study) mutant cells are defective in HR. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Eukaryotic chromatin is regulated by chromatin factors such as histone modification enzymes, chromatin remodeling complexes and histone chaperones in a variety of DNA-dependent reactions. Among these reactions, transcription in the chromatin context is well studied. On the other hand, how other DNA-dependent reactions, including postreplicative homologous recombination, are regulated in the chromatin context remains elusive. Here, histone H3 Lys56 acetylation, mediated by the histone acetyltransferase Rtt109 and the histone chaperone Cia1/Asf1, is shown to be required for postreplicative sister chromatid recombination. This recombination did not occur in the cia1/asf1-V94R mutant, which lacks histone binding and histone chaperone activities and which cannot promote the histone acetyltransferase activity of Rtt109. A defect in another histone chaperone, CAF-1, led to an increase in acetylated H3-K56 (H3-K56-Ac)-dependent postreplicative recombination. Some DNA lesions recognized by the putative ubiquitin ligase complex Rtt101-Mms1-Mms22, which is reported to act downstream of the H3-K56-Ac signaling pathway, seem to be increased in CAF-1 defective cells. Taken together, these data provide the framework for a postreplicative recombination mechanism controlled by histone modifiers and histone chaperones in multiple ways.
    Genes to Cells 09/2010; 15(9):945-58. DOI:10.1111/j.1365-2443.2010.01435.x · 2.81 Impact Factor
Show more


4 Reads
Available from